The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Santini Gino since 2017.
This trader's CIK number is 1276038.
At the time of last reporting, Santini Gino was the Director of Collegium Pharmaceutical, Inc. (stock ticker symbol COLL).
Also see all insider trading activities at Collegium Pharmaceutical, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | HZNP | 0 | $0 | 0 | $0 | 47,005 | $670,891 |
| 2022 | HZNP | 0 | $0 | 0 | $0 | 4,223 | $0 |
| 2021 | HZNP | 0 | $0 | 12,000 | $1,097,604 | 0 | $0 |
| 2020 | HZNP | 0 | $0 | 0 | $0 | 51,185 | $115,152 |
| 2019 | HZNP | 0 | $0 | 0 | $0 | 15,320 | $0 |
| 2018 | HZNP | 0 | $0 | 0 | $0 | 14,054 | $0 |
| 2017 | HZNP | 0 | $0 | 0 | $0 | 13,953 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | COLL | 0 | $0 | 5,405 | $201,017 | 15,000 | $201,750 |
1. Horizon Therapeutics Public Ltd Co (HZNP)
2. Collegium Pharmaceutical, Inc (COLL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-02 | HZNP | Option Ex | 23,092 | 15.23 | 351,691 |
| 2023-09-22 | HZNP | Option Ex | 20,000 | 15.96 | 319,200 |
| 2023-04-28 | HZNP | Option Ex | 3,913 | .00 | 0 |
| 2022-04-29 | HZNP | Option Ex | 4,223 | .00 | 0 |
| 2021-03-01 | HZNP | Sale | 12,000 | 91.47 | 1,097,604 |
| 2020-08-03 | HZNP | Option Ex | 35,795 | 3.22 | 115,152 |
| 2020-05-02 | HZNP | Option Ex | 15,390 | .00 | 0 |
| 2019-05-03 | HZNP | Option Ex | 15,320 | .00 | 0 |
| 2018-05-03 | HZNP | Option Ex | 14,054 | .00 | 0 |
| 2017-05-03 | HZNP | Option Ex | 13,953 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-15 | COLL | Option Ex | 15,000 | 13.45 | 201,750 |
| 2025-08-15 | COLL | Sale | 5,405 | 37.19 | 201,017 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Santini Gino (Director of Collegium Pharmaceutical, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.